Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Omada Health (OMDA) EBIT (2024 - 2025)

Omada Health (OMDA) has disclosed EBIT for 2 consecutive years, with $3.3 million as the latest value for Q4 2025.

  • Quarterly EBIT rose 146.21% to $3.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$10.7 million through Dec 2025, changed N/A year-over-year, with the annual reading at -$12.0 million for FY2025, 72.58% up from the prior year.
  • EBIT hit $3.3 million in Q4 2025 for Omada Health, up from -$2.5 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $3.3 million in Q4 2025 to a low of -$10.0 million in Q2 2024.